Case of the Month

November 2025

69-year-old patient with immune-related SJS/TEN overlap after PD-L1 inhibitor therapy

Read more
Oktober 2025

39-year-old patient with ICANS after ICI therapy

Read more
September 2025

80-year-old male patient with Nivolumab induced Multi-Toxicity

Read more
Juli 2025

65-year-old male patient with Pembrolizumab-induced Lichen planus

Read more
April 2025

71-year-old male patient with Ipilimumab/Nivolumab-induced Triple M syndrome (Myasthenia gravis, Myositis, Myocarditis)

Read more
August 2024

60-year-old male patient with Nivolumab-induced polyarthritis and suspected necrotizing fasciitis

Read more
August 2023

44-year old female patient with pembrolizumab-induced polyserositis

Read more
April 2023

56-year old melanoma patient with positive test for purkinje cell cytoplasmatic antibody

Read more

Participate and document cases of rare, complex, severe and therapy-refractory side effects induced by immunotherapy

Join our team of experts for analysis of irAE

Initiate or contribute to research projects with regard to irAE

Access our Database